Most Recent
Wicked Sister dessert maker suffers loss in trade mark battle
The company that makes Wicked Sister desserts has suffered a defeat in its trade mark battle against the maker of Wicked dipping sauces, with a judge removing some of its trade marks from the register.
Sandoz wins appeal of $26.3M infringement ruling in IP battle over Lexapro
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.
Telstra sues Optus over ‘more than ever before’ ad campaign
Telstra has filed a lawsuit accusing Singtel Optus of breaching the Australia Consumer Law through ads that claim it is "covering more of Australia than ever before".
What barristers love and loathe about their instructing solicitors
When it comes to briefing barristers, solicitors lie on a spectrum of awesome to irksome. In a series of interviews with Lawyerly, some of Australia's top counsel reveal what they like and what they don't like about their instructing lawyers.
Virgin bondholders fail to get hands on confidential Bain Capital sale docs
Virgin Australia unsecured bondholders contesting the sale of the embattled airline to private equity firm Bain Capital have failed in their bid to access confidential transaction documents, but a judge has urged the administrators to communicate with the frustrated creditors.
Virgin bondholders blast Deloitte disclosures to court
Virgin Australia bondholders contesting the sale of the airline to private equity firm Bain Capital have blasted the airline's administrators at Deloitte for failing to inform the court when applying for confidentiality orders that the bondholders had sought information on the terms of the deal.
The race for the COVID-19 vaccine and patents: Do we need a temporary lockdown?
It is entirely possible that the first effective SARS-CoV-2 vaccine is developed in Australia, with an Australian firm securing patent rights to the vaccine. If that occurs, it is important to remember that a patent is not an impenetrable fortress. Patent laws already contain mechanisms to enable "special access" to patented pharmaceuticals and other technologies, including (perhaps especially) in times like this, say James Neil and Richard Hoad of Clayton Utz.
Special purpose liquidators appointed by judge to investigate claims against Phoenix directors
A judge has appointed special purpose liquidators to investigate the affairs of failed VET provider Phoenix Institute and its directors after the Commonwealth complained of "a difficult working relationship" with the training company's current liquidators.
Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract "incorporeal" genetic information that is naturally found within the DNA of an unborn foetus.
Virgin administrators sign deal with Bain Capital to buy struggling airline
Virgin's administrators have reached a deal with Bain Capital to buy the airline and its subsidiaries, saying Friday US investment firm had made a "strong and compelling" bid to keep Australia’s second airline operating and secure the jobs of thousands of workers.